Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Hemogenyx Pharmaceuticals PLC | 1,187,959 | net | 29 Jun 2020 | tx 3+1,187,959 |
| Latham (James) PLC | 784 | net | 03 Jan 2019 | tx 2+784 |
| JAMES LATHAM PUBLIC LIMITED COMPANY | 486 | net | 08 Jan 2026 | tx 1+486 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 08 Jan 2026 | OTHER | JAMES LATHAM PUBLIC LIMITED COMPANY | 486 | 9.25 GBP | |
| 29 Jun 2020 | PURCHASE | Hemogenyx Pharmaceuticals PLC | 90,554 | 0.06 GBP | |
| 30 Jan 2020 | PURCHASE | Hemogenyx Pharmaceuticals PLC | 257,069 | 0.02 GBP | |
| 30 Apr 2019 | PURCHASE | Hemogenyx Pharmaceuticals PLC | 840,336 | 0.02 GBP | |
| 03 Jan 2019 | PURCHASE | Latham (James) PLC | 718 | 6.26 GBP | |
| 02 Feb 2018 | OTHER | Latham (James) PLC | 66 | 7.92 GBP |